Sana Biotechnology, Inc. (SANA)
3.20
+0.15
(+4.92%)
USD |
NASDAQ |
Apr 02, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Shareholders Equity (Quarterly) : 160.88M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Illumina, Inc. | 2.723B |
| Eli Lilly & Co. | 26.54B |
| Pacific Biosciences of California, Inc. | 5.349M |
| Beam Therapeutics, Inc. | 1.238B |
| ImmunityBio, Inc. | -500.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 426.72M |
| Total Liabilities (Quarterly) | 265.84M |
| Debt to Equity Ratio | 0.4902 |
| Current Ratio | 1.888 |
| Net Debt Paydown Yield | 0.32% |